Time running out for pharma sales and marketing

February 26, 2009
Research and Development, Sales and Marketing pwC, strategy

The pharma industry's current sales and marketing model will be defunct in the next ten years. That is the stark …

Virgo wins major new diabetes launch account

February 26, 2009
Medical Communications Virgo

London-based healthcare PR specialist Virgo Health has won the UK account for new diabetes drug Onglyza. Due to be launched …

Europe approves Lilly’s Plavix rival

February 25, 2009
Research and Development, Sales and Marketing Daiichi, Effient, lilly

Lilly and Daiichi Sankyo have won European approval for their blood-thinning drug Efient, which will go up against established blockbuster …

Genentech urges shareholders to reject Roche bid

February 24, 2009
Sales and Marketing Genentech, Roche

The battle for the future of Genentech has heated up after the company's board asked its shareholders to reject Roche's …

NovaBiotics: a rising star for 2009

February 24, 2009
Research and Development NovaBiotics

Biologics company NovaBiotics has been dubbed a Rising Star for 2009 by the Scottish arm of the BioIndustry Association. The …

R&D tax credits among anticipated changes for US healthcare

February 24, 2009
Research and Development US, healthcare

With the election of Barack Obama, widespread changes are anticipated for US healthcare and ultimately for the pharmaceutical industry. Although …

Bringing global trials teams together

February 23, 2009
Research and Development clinical trials, global

The world is getting bigger and smaller at the same time. When the internet began to really catch on about …

Roche rejoins ABPI after six-month suspension

February 23, 2009
Sales and Marketing Code of Practice, Roche

Roche has been allowed to rejoin the ranks of the ABPI, after its six-month suspension for bringing discredit on the …

Shire acquires ADHD presence in Europe

February 23, 2009
Sales and Marketing ADHD, Shire

Shire has bought the global rights for two established treatments for Attention Deficit Hyperactivity Disorder from UCB. The acquisition gives …

CV Therapeutics rejects Astellas takeover bid

February 23, 2009
Sales and Marketing Astellas, CV Therapeutics

Biotech company CV Therapeutics has rejected a second take-over offer from Astellas, saying the Japanese group failed to recognise its …

The Pharmafocus interview: Simon Jose

February 20, 2009
Sales and Marketing GlaxoSmithKline, Simon Jose, UK, partnerships, pricing

Like all his contemporaries in the UK, Simon Jose, GlaxoSmithKline’s head of UK   operations has to focus on some of …

Raptiva suspended in Europe over safety concerns

February 20, 2009
Research and Development, Sales and Marketing Europe, Rapitva

Psoriasis treatment Raptiva is to be suspended from use in the European Union because of concerns about rare but serious …

Servier claims victory over NICE in osteoporosis

February 19, 2009
Research and Development, Sales and Marketing NICE, Servier

Servier has claimed victory in the first round of its legal battle against NICE's guidelines on osteoporosis.A judicial review requested …

GSK’s diabetes candidate enters phase III

February 19, 2009
Research and Development GSK, diabetes

A large scale study of GlaxoSmithKline's type II diabetes candidate Syncria (albiglutide) has begun.Albiglutide is an investigational biological drug, and …

Anger over private firm’s role in prescribing controls

February 19, 2009
NHS

Pharmacy and GP representatives have attacked plans for a private company to oversee primary care prescribing costs.Private provider Assura is …

Sanofi-Aventis joins YouTube revolution

February 18, 2009
Sales and Marketing Sanofi-Aventis, diabetes

Sanofi-Aventis has launched its first YouTube channel, aimed at diabetes sufferers in the US.Reached by typing the keyword goinsulin into …

Genzyme says new plant approval is imminent

February 18, 2009
Research and Development, Sales and Marketing Genzyme

Genzyme has said it expects to get approval to make a Pompe disease treatment at a new US manufacturing unit …

Novartis and charity team up on AMD campaign

February 18, 2009
Medical Communications, Sales and Marketing AMD, ophthalmology

Novartis has teamed up with blindness charity the RNIB on a new campaign to promote awareness of age-related macular degeneration …

Lilly to boost biotech stake in NeuroSearch deal

February 17, 2009
Research and Development Denmark, Europe, NeuroSearch

Lilly has signed a new deal with Danish biotech company NeuroSearch and increased its presence further in the biologics sector.The …

The Gateway to Local Adoption Series

Latest content